This article considers the challenges and potential benefits of combining the two. The nasal delivery of biologics offers considerable potential for both local and systemic action and for direct access to the brain and CNS to address currently unmet therapeutic need. The unique features of biologics are discussed with reference to the associated difficulties of nasal delivery and the benefits of partnership with experts such as Aptar Pharma is highlighted. Work on the development of vaccines and prophylactics for COVID-19 illustrates what is achievable.
Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery
This Might Also Be of Interest
Optimising Preclinical Studies for Intranasal and Pulmonary Programmes
Publications, Pharmaceutical, Product Solutions, Device Innovations, Market Insights
Targeted Aerosol Delivery to NALT Using BiVax Intranasal Atomizer
Publications, Pharmaceutical, Market Insights, Product Solutions, Device Innovations
PureHale® & The Future of Fine Mist Dispensers for Upper Airway Treatments
Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions
Acute Migraine Relief: Nose-to-Brain Delivery with Lipid Nanoparticles
Publications, Pharmaceutical, Device Innovations, Market Insights, Product Solutions
